Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

mAbs

Showing results (391-400 of 1,833) with videos related to

Pageof 184
Sort By:
Mabs|February 21, 2024
Production of antibodies and antibody fragments containing non-natural amino acids in <i>Escherichia coli</i>Jacquelyn Blake-Hedges, Dan Groff, Wilson Foo, et al.
Mabs|October 12, 2023
Utility of physiologically based pharmacokinetic modeling to predict inter-antibody variability in monoclonal antibody pharmacokinetics in miceShufang Liu, Sara C Humphreys, Kevin D Cook, et al.
Mabs|July 6, 2023
Improved antibody pharmacokinetics by disruption of contiguous positive surface potential and charge reduction using alternate human frameworkRomain Ollier, Aline Fuchs, Florence Gauye, et al.
Mabs|July 6, 2023
Therapeutic index improvement of antibody-drug conjugatesHans-Peter Gerber, Sanjeev Gangwar, Alison Betts
Mabs|August 23, 2023
Targeted chain-exchange-mediated reconstitution of a split type-I cytokine for conditional immunotherapyVedran Vasic, Can Buldun, Manfred Ritz, et al.
Mabs|August 21, 2023
Selection of bispecific antibodies with optimal developability using FcRn‑Ph‑HPLC as an optimized FcRn affinity chromatography methodThomas Müller, Carolin Tasser, Michael Tesar, et al.
Mabs|August 23, 2023
A machine learning strategy for the identification of key <i>in silico</i> descriptors and prediction models for IgG monoclonal antibody developability propertiesAndrew B Waight, David Prihoda, Rojan Shrestha, et al.
Mabs|September 7, 2023
Biophysical characterization of PVR family interactions and therapeutic antibody recognition to TIGITSj J Diong, Aarti Jashnani, Andrew W Drake, et al.
Mabs|June 29, 2023
Modifying antibody-FcRn interactions to increase the transport of antibodies through the blood-brain barrierJason Tien, Dmitri Leonoudakis, Ralitsa Petrova, et al.
Mabs|June 8, 2023
Generation of a novel fully human non-superagonistic anti-CD28 antibody with efficient and safe T-cell co-stimulation propertiesAbdullah Elsayed, Christian Pellegrino, Louis Plüss, et al.
Pageof 184

Showing results (391-400 of 1,833) with videos related to

Sort By:
Pageof 184
Mabs|February 21, 2024
Production of antibodies and antibody fragments containing non-natural amino acids in <i>Escherichia coli</i>Jacquelyn Blake-Hedges, Dan Groff, Wilson Foo, et al.
Mabs|October 12, 2023
Utility of physiologically based pharmacokinetic modeling to predict inter-antibody variability in monoclonal antibody pharmacokinetics in miceShufang Liu, Sara C Humphreys, Kevin D Cook, et al.
Mabs|July 6, 2023
Improved antibody pharmacokinetics by disruption of contiguous positive surface potential and charge reduction using alternate human frameworkRomain Ollier, Aline Fuchs, Florence Gauye, et al.
Mabs|July 6, 2023
Therapeutic index improvement of antibody-drug conjugatesHans-Peter Gerber, Sanjeev Gangwar, Alison Betts
Mabs|August 23, 2023
Targeted chain-exchange-mediated reconstitution of a split type-I cytokine for conditional immunotherapyVedran Vasic, Can Buldun, Manfred Ritz, et al.
Mabs|August 21, 2023
Selection of bispecific antibodies with optimal developability using FcRn‑Ph‑HPLC as an optimized FcRn affinity chromatography methodThomas Müller, Carolin Tasser, Michael Tesar, et al.
Mabs|August 23, 2023
A machine learning strategy for the identification of key <i>in silico</i> descriptors and prediction models for IgG monoclonal antibody developability propertiesAndrew B Waight, David Prihoda, Rojan Shrestha, et al.
Mabs|September 7, 2023
Biophysical characterization of PVR family interactions and therapeutic antibody recognition to TIGITSj J Diong, Aarti Jashnani, Andrew W Drake, et al.
Mabs|June 29, 2023
Modifying antibody-FcRn interactions to increase the transport of antibodies through the blood-brain barrierJason Tien, Dmitri Leonoudakis, Ralitsa Petrova, et al.
Mabs|June 8, 2023
Generation of a novel fully human non-superagonistic anti-CD28 antibody with efficient and safe T-cell co-stimulation propertiesAbdullah Elsayed, Christian Pellegrino, Louis Plüss, et al.
Pageof 184